Rivaara Labs logo — Pioneering precision in diagnostics with timely, actionable...

Rivaara Labs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes.

Founded 2019 51-200 employees Private Equity Total: $600.00M Biotechnology, Health Care

General Information

Company Name Rivaara Labs
Founded Year 2019
Employees 51-200
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

Get notified when Rivaara Labs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rivaara Labs

Rivaara Labs, founded in 2019, is a biotechnology and healthcare startup focused on advancing precision diagnostics with timely, actionable solutions for improved healthcare outcomes. The company's offerings include molecular diagnostics services, clinical testing solutions, and innovative Point of Care (POC) solutions. With a strategic emphasis on building a wide network of specialized Molecular Diagnostics labs and a national reference lab, Rivaara Labs addresses the critical need for prompt, actionable information that transcends the limitations of current diagnostic and monitoring practices. The company's open, dynamic, and collaborative culture empowers teams to drive innovation in the healthcare space. In its latest funding round on 07 November 2022, Rivaara Labs secured a substantial INR600.00M investment from Kotak Investment Advisors, BHARAT V. DAFTARY, and Amicus Capital, showcasing confidence from prominent investors in the startup's vision. Rivaara Labs' commitment to bridging the gap in precision diagnostics positions it as a promising player in the biotechnology and healthcare industries, offering compelling opportunities for potential stakeholders and investors.

Taxonomy: Precision Diagnostics, Molecular Diagnostics, Clinical Testing, Point of Care Solutions, Healthcare Innovation, Medical Technology, RT-PCR, NGS (Next Generation Sequencing), Pharmaceuticals, Research, Healthcare Analytics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round INR600.00M 3 BHARAT V. DAFTARY, Amicus Capital 07 Nov 2022

Rivaara Labs Alternatives & Competitors

Rivaara Labs vs
NeoDx
NeoDx India

Precision Diagnostics: Reliable Results, Affordable Solutions

33 employees
Biotechnology, Health Care
Rivaara Labs vs
UgenTec
UgenTec Belgium

Sample Flow Intelligence

Acquired
3 employees
Biotechnology, Health Care
Rivaara Labs vs

Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized in...

Seed
10 employees
Biotechnology, Health Care

FAQ About Rivaara Labs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes.
Rivaara Labs was founded in 2019.
Rivaara Labs operates in the following industries: Biotechnology, Health Care.
Rivaara Labs has approximately 51-200 employees.
Rivaara Labs has completed 1 funding round, raising a total of $600.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Rivaara Labs include NeoDx , UgenTec, Qualisure Diagnostics Inc., Molecular Testing Labs, Zalma Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rivaara Labs and NeoDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rivaara Labs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy